Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
about
Zinc finger point mutations within the WT1 gene in Wilms tumor patientsThe Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of JanusWhole-genome analysis informs breast cancer response to aromatase inhibitionTumor-suppressor genes: cardinal factors in inherited predisposition to human cancersTransgenic models of retinoblastoma: what they tell us about its cause and treatmentPolymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.Melanoma: Molecular Pathogenesis and Therapeutic ManagementLoss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation indexp53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus statusp53 mutations and overexpression in locally advanced breast cancersMutations in p53 do not account for heritable breast cancer: a study in five affected families.p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptorAlteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.Study of mutations in p53 tumour suppressor gene in human sporadic breast cancersAllelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-upneu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.Molecular genetics of familial breast-ovarian cancerMutations in p53 as potential molecular markers for human breast cancer.A temperature-sensitive mutant of human p53.Pubertal high fat diet: effects on mammary cancer development.p53 expression in lymphatic malignancies.p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.p53 gene mutations in multiple myeloma.p53 overexpression in Ewing's sarcoma/primitive neuroectodermal tumour is an uncommon event.p53 is frequently mutated in Burkitt's lymphoma cell lines.Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.Constitutional p53 mutation in a non-Li-Fraumeni cancer family.p53 expression in colorectal adenomas.Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancerExclusion of constitutional p53 mutations as a cause of genetic susceptibility to colorectal cancer.Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.Analysis of oncogenes and tumor suppressor genes in human breast cancer.Detection of p53 gene mutations in aspiration biopsy specimens from suspected breast cancers by polymerase chain reaction-single strand conformation polymorphism analysis.
P2860
Q24561664-D9CE23C0-83B7-4EF3-B8F2-0D2D0B336F76Q26740184-C3FC0A39-49AD-4DD9-8A0A-8DBD7937A375Q28269291-AE75C763-57F1-493B-AA04-9647BE8A84CEQ30499489-C35E9B4D-80FD-4520-8475-8B13564CD32EQ34164124-3D9CE64F-913B-4D2E-867C-0315AE4EDE12Q34638831-F7EEE0B0-C6A8-4A76-9D9E-7521BEA035ECQ35137163-657A089D-0AD1-4F92-90E2-67A9CC63AC14Q35830902-B370470A-731A-493B-BCDE-3FF68A0BF073Q35978167-B9E67E7B-61AF-40EF-B080-2B78BF2B7C56Q35979192-FA3CBF30-E2CD-4BAB-A862-ECC7165D84B7Q35982987-6F369D7A-CD61-4B93-AC88-C93374E56F08Q35994464-FC8C2AE8-07D1-4BD1-B5A4-C72A9D3ECA53Q36080644-CA1EDAF0-37C0-490D-8444-6EB2DB990238Q36136114-69CE41E1-5683-4FB2-840E-F9A0E1E70DD5Q36136580-01FA5606-F60C-4A3B-9DE4-975C6B9A4FA2Q36263661-278B672F-7307-4222-94EE-277E882058DEQ36291835-D56D5451-07A7-48F7-8301-1D8CE72006FAQ36568624-A000F13B-725A-4508-8FC8-079E501E66F8Q37142419-48422852-4852-4DE8-A340-D51D33F71668Q37266801-F0B84FF6-8559-41BA-9234-BBD231C145A4Q37632816-8414D1F7-E534-4894-AAAD-AE3B3A8F41C7Q37632919-35D80DCE-CDFA-4976-B5D1-158F4823977BQ37690070-0581BEA6-963B-4172-9D5C-DC81B5E6B067Q39398079-36DCE37E-FDE5-4417-BE7A-F1D47CD5F397Q39625336-599188A9-B3DC-4681-9E8B-AB60D5E201A4Q40727007-C99CC8A5-CA98-49A9-8177-8F5012EB9DDFQ40848687-DE596931-3C2E-49E3-B9AE-CDFF025966AFQ41082472-315F27C2-82CF-498C-8E2B-E366F70B7880Q41462464-E94C4AC0-6591-4699-B399-A7C259927D89Q41818611-1AAD4C67-EFC9-4F6A-8D41-ABEC06557866Q41873922-1E8205BB-8EFE-473C-9ED0-6FBBDF3A10E1Q41896494-8C6DCFEB-681F-46F2-A41C-8F58864B66A3Q41971466-B6394745-BAA3-4387-96FD-FA98FCFC5821Q41974075-ABCCDC5E-9DEF-442C-82BD-5B702CAD63A1Q55006724-E0330861-636A-4B88-B7D5-C42036DA46DDQ55235050-B6857B64-6265-43DA-8A2F-098EDF77EB74Q55387322-F53EF1F0-ADDB-4D4D-BDF8-D701E9921CBEQ55419803-692E8727-B83E-45A9-925D-CAD37BC42C81
P2860
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
@en
type
label
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
@en
prefLabel
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
@en
P2093
P1433
P1476
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
@en
P2093
P304
P407
P577
1990-10-01T00:00:00Z